ArticleNature communications2019
A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host.
Christian M Harding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this papercites it